Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Cholesterol synthesis; Noncholesterol sterols; Genetic hypercholesterolemias; Familial combined hyperlipidemia; Body mass index;
مقالات ISI هیپرلیپیدمی ترکیبی خانوادگی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Children; Primary hyperlipidemia; Hazelnuts; Serum lipids; Omega-3 index; Erythrocyte fatty acids; BMI; body mass index; CVD; cardiovascular disease; CHILD; cardiovascular health integrated lifestyle diet; FA; fatty acid; FCHL; familial combined hyperlipi
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; AUC; area under the curve; dAUC; incremental integrated area under the curve; FCH; familial combined hyperlipidemia; OGTT; oral glucose tolerance test; T2DM; type 2 diabetes mellitus; Inflammation; Integrin; Diabetic complications; Atherosclerosis;
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Diabetes mellitus; Statins; Heterozygous familial hypercholesterolemia; Familial combined hyperlipidemia;
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Carotid intima-media thickness; Subclinical atherosclerosis; Atherosclerosis progression; Cardiovascular risk; Familial hypercholesterolemia; Familial combined hyperlipidemia; Autosomal dominant hypercholesterolemia;
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; AAV1; adeno-associated virus serotype 1; ACC; American College of Cardiology; ACCELERATE; A Study of Evacetrapib in High-Risk Vascular Disease; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADA; American Diabetes Association; AMP; adenosine m
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Lipid metabolism; Cholesterol; LDL; PCSK9; FCHL; FCHL; familial combined hyperlipidemia; LDLR; LDL receptor; PCSK9; proprotein convertase subtilisin kexin type 9; SREBP2; sterol regulatory element binding protein 2; LDL-C; LDL cholesterol; HDL-C; HDL chol
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Plant sterols; Phytosterols; Familial hyperlipidemias; Dietary patterns; Dietary compliance; CVD; cardiovascular disease; ADH; autosomal dominant hypercholesterolemia; FCHL; familial combined hyperlipidemia; TC; total cholesterol; BMI; body mass index; CR
Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; LDL-C; Familial combined hyperlipidemia; Non-HDL-C; Apolipoprotein B; Cardiovascular risk;
Calculating LDL cholesterol in familial combined hyperlipidemia: Out with the old, in with the new?
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Low-density lipoprotein cholesterol; Familial combined hyperlipidemia;
Effect of short-term hazelnut consumption on DNA damage and oxidized LDL in children and adolescents with primary hyperlipidemia: a randomized controlled trial
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; FCHL; familial combined hyperlipidemia; FH; familial hypercholesterolemia; FPG; formamidopyrimidine DNA glycosylase; HDL-C; high-density lipoprotein cholesterol; HZN+S; hazelnuts
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Natural products; Nuclear receptors; Liver X receptor; Farnesoid X receptor; Retinoid X receptor; Metabolic syndrome; Precision medicine; 6-ECDCA; 6α-ethyl-chenodeoxycholic acid (obeticholic acid); AA; arachidonic acid; ABC; ATP-binding cassette transpor
Type III Hyperlipoproteinemia: Still Worth Considering?
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; apo; apolipoprotein; CHD; coronary heart disease; CM; chylomicron; FCH; familial combined hyperlipidemia; HDL-C; high-density lipoprotein cholesterol; HLP; hyperlipoproteinemia; HSPG; heparan sulfate proteoglycan; LDL; low-density lipoprotein; LDL-C; low-
Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial hypercholesterolemia; Familial combined hyperlipidemia; Lipoprotein(a); Coronary artery disease; Mutation negative;
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Single nucleotide polymorphism (SNP); Apolipoprotein A-V (APOA5); Upstream stimulatory factor 1 (USF1)APOA5, Apolipoprotein A-V; ApoB, Apolipoprotein B; APOC3, Apolipoprotein C-III; APOE, Apolipoprotein E; CETP, cholester
Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Apolipoprotein CIII; VLDL triglyceride content; VLDL particle number; Familial combined hyperlipidemia;
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; LDLR gene; LPL gene; Rare mutations; Polymorphisms; Familial combined hyperlipidemia; Resequencing; Association study;
Control del colesterol-LDL en pacientes con dislipidemias genéticas seguidos en unidades de lípidos y riesgo vascular de la Sociedad Española de Arteriosclerosis
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Hipercolesterolemia familiar; Hiperlipidemia familiar combinada; Estatinas; EzetimibaFamilial hypercholesterolemia; Familial combined hyperlipidemia; Statins; Ezetimibe
Hipercolesterolemias genéticas
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Hipercolesterolemia familiar; Hiperlipidemia familiar combinada; PCSK9; Sitosterolemia; Genética; Colesterol LDLFamilial hypercholesterolemia; Familial combined hyperlipidemia; PCSK9; Sitosterolemia; Genetics; Cholesterol LDL
Prise en charge des hypertriglycéridémies sévères
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Chylomicrons; hyperchylomicronémie; hypertriglycéridémie; dysbétalipoprotéinémie; hyperlipidémie combinée familiale; Chylomicrons; hyperchylomicronemia; hypertriglyceridemia; dysbetalipoproteinemia; familial combined hyperlipidemia;
Arteriosclerosis carotídea subclínica en pacientes con hiperlipidemia familiar combinada. Evolución tras dos años de tratamiento con dosis altas de atorvastatina
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Grosor íntima-media; Arteria carótida; Arteriosclerosis; Hiperlipidemia familiar combinada; AtorvastatinaIntima-media thickness; Carotid artery; Atherosclerosis; Familial combined hyperlipidemia; Atorvastatin
Therapeutic approaches to drug targets in hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; drug targets; hyperlipidemia; lanosterol synthase inhibitors; squalene synthase inhibitors; ACAT; Acyl-Co A: cholesterol acyltransferase; AMPK; AMP-activated protein kinase; apoB; Apolipoprotein B; ATP III; adult Treatment Panel III; CETP; cholesteryl est
Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effect of statins. A systematic review and meta-analysis
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial hypercholesterolemia; Familial combined hyperlipidemia; Atherosclerosis; Endothelium; Flow-mediated dilation; Intima-media thickness; Meta-analysis;
Carotid distension and distensibility impairment in individuals affected by familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Carotid distensibility; Carotid distension; Ultrasound; Atherosclerosis
Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Insulin resistance; Xanthine oxidase; Nuclear factor kappa B; Inflammation
Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; PNPLA2 gene; Polymorphisms; Familial combined hyperlipidemia; Triglycerides; Association study
Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Small dense LDL; Metabolic syndrome;
Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Small dense LDL cholesterol; Precipitation; Triglyceride; ApolipoproteinB
Endothelial haemostatic markers in members of families with familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; ACE; angiotensin converting enzyme; AI; atherogenic index; ANOVA; analysis of variance; apoB; apolipoprotein B; apoE2; apolipoprotein E2; BMI; body mass index; CCA; common carotid artery; CHD; coronary heart disease; DBP; diastolic blood pressure; ELISA;
Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: Association study in 2000 Dutch Caucasians
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Genetic association study; Single nucleotide polymorphism; Familial combined hyperlipidemia; Complex genetic diseases; Type 2 diabetes; Insulin resistance
Adiponectin multimer distribution in patients with familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Adiponectin multimers; Adiponectin multimer distribution; Familial combined hyperlipidemia; Cardiovascular disease; Cardiovascular risk; Adiponectin sensitivity index;
Insulin resistance and oxidative stress in familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Insulin resistance; Oxidative stress; Atherosclerosis
Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Sonography; Carotid IMT; Carotid plaque; Metabolic syndrome; Apolipoprotein B/apolipoprotein A-I ratio;
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; HDL deficiency; APOA1 gene mutation; Familial combined hyperlipidemia; Cardiovascular disease
Frequency of Low-Density Lipoprotein Receptor Gene Mutations in Patients With a Clinical Diagnosis of Familial Combined Hyperlipidemia in a Clinical Setting
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; familial combined hyperlipidemia; familial hypercholesterolemia; LDLR mutationsApo, apolipoprotein; CI, confidence interval; FCH, familial combined hyperlipidemia; FH, familial hypercholesterolemia; LDL, low-density lipoprotein; LDLR, low-density lipoprot
Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Pulse pressure; Apolipoprotein B; Glucose
Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Heterozygous familial hypercholesterolemia; Familial combined hyperlipidemia; Lipids; Cardiovascular risk factors; Coronary artery disease;
Pulse Wave Velocity in Familial Combined Hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; pulse wave velocity; augmentation index; cardiovascular risk stratification; arterial stiffness; pulse wave analysis;
Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia (FCH)
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Intima media thickness; Remnant lipoproteins
Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Familial hypertriglyceridemia; Familial hypercholesterolemia; Metabolic syndrome; Apolipoprotein B
Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; APOA5 gene; Haplotype; Triglyceride level; Intima-media thickness; Remnant-like particle
Hiperlipidemia familiar combinada, sÃndrome metabólico y enfermedad cardiovascular
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Hiperlipidemia familiar combinada; SÃndrome metabólico; Insulinorresistencia; Infarto agudo de miocardio; Familial combined hyperlipidemia; Metabolic syndrome; Insulin resistance; Acute myocardial infarction;
OriginalesEfecto del género y de la obesidad en la lipemia posprandial en sujetos sanos normolipidémicos no diabéticos y sujetos con hiperlipemia familiar combinadaEffect of gender and obesity on postprandial lipemiain non-diabetic normolipidemic subje
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; lipemia posprandial; hiperlipemia familiar combinada; triglicéridos capilares diurnos; obesidad; postprandial lipemia; familial combined hyperlipidemia; diurnal capillary triglycerides; obesity;
Perfil diurno de triglicéridos en sujetos con hiperlipidemia familiar combinada de una población del sur de Europa
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Lipidemia posprandial; Hiperlipidemia familiar combinada; Resistencia a la insulina; Obesidad; Postprandial lipidemia; Familial combined hyperlipidemia; Insulin resistance; Obesity;
Tumor necrosis factor alpha (TNFα) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL)
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; TNFα; TNF-α receptors; Lipoproteins; NEFA; HOMAIR;
Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Apolipoprotein A-II; Familial combined hyperlipidemia; Fibrate; Peroxisome-proliferator-activated receptor α; Very-low-density lipoprotein;
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; Familial combined hyperlipidemia; Small dense LDL; Statins;
Visión actualizada de la hiperlipidemia familiar combinada aplicada a la mejora de su diagnóstico
Keywords: هیپرلیپیدمی ترکیبی خانوادگی; ApoproteÃna B; Aterosclerosis; Cribado; Diagnóstico; Genética; Hiperlipidemia familiar combinada; Apoprotein B; Atherosclerosis; Screening; Diagnosis; Genetics; Familial combined hyperlipidemia;